J. Gram et al., Inhalation/intravenous recombinant tissue plasminogen activator and inhaled heparin in a patient with acute respiratory distress syndrome, FIBRINOL PR, 13(4-5), 1999, pp. 209-212
Recent studies have demonstrated that lung fibrin deposits are associated w
ith evolution of acute respiratory distress syndrome (ARDS). A young woman
with ARDS resistant to conventional treatment was treated with ultrasonic n
ebulized rt-PA (30 mg) and intravenous rt-PA (20 mg) over 2 h followed by c
ontinuous treatment with ultrasonic nebulized unfractionated heparin (15 00
0 IU/day). The pulmonary gas exchange of the patient improved significantly
and the condition of the patient stabilized during the hours following the
fibrinolytic treatment. The potential use of nebulized thrombolytics for l
ocal treatment of ARDS is discussed, and we conclude that combined nebulize
d and intravenous therapy with thrombolytics may improve physiologic derang
ements associated with acute lung injury in ARDS. (C) Harcourt Publishers L
td 1999.